EBOS Group (ASX: EBO) — Perfil da empresa, notícias e dados financeiros
EBOS Group is an Australasian distributor of healthcare and pharmaceutical products, with over 5,000 employees across the region.
EBOS Group
EBOS Group is an Australasian marketer, wholesaler, and distributor of healthcare, medical, and pharmaceutical products, as well as animal care brands. The company operates across two main divisions: Healthcare and Animal Care. Its healthcare operations encompass pharmaceutical wholesaling to community pharmacies, institutional healthcare supply to hospitals and aged care facilities, medical technology and device distribution, and consumer products. Its animal care segment manufactures and distributes premium pet food, treats, and healthcare products across retail and veterinary channels. Operating across Australia, New Zealand, and Southeast Asia, the company distributes products through extensive logistics infrastructure and retail pharmacy networks.
Resumo
Operações
Produtos e/ou serviços de EBOS Group
- Community Pharmacy Wholesale: Distribution of prescription medicines, over-the-counter products, and retail merchandise to thousands of independent and franchise pharmacies across Australia and New Zealand, providing daily delivery services through specialized distribution centers.
- Institutional Healthcare Distribution: Supply of pharmaceuticals, medical consumables, and specialized health products to public and private hospitals, day surgeries, aged care facilities, and government healthcare entities across Australia and New Zealand through automated fulfillment networks.
- Contract Logistics Services: Provision of third-party logistics, cold-chain warehousing, inventory management, and clinical trial distribution services for global pharmaceutical and healthcare manufacturers operating across Australasia and selected markets in Southeast Asia.
- Medical Devices and Technology: Distribution of specialized medical devices, surgical equipment, implants, and diagnostic consumables to healthcare professionals, hospitals, and surgical centers, supported by technical training and clinical support specialists across Australasia.
- Retail Pharmacy Brand Support: Support services for community pharmacy networks, encompassing brand management, franchise administration, retail marketing campaigns, point-of-sale systems, and private-label consumer product ranges supplied to retail pharmacy partners.
- Animal Care Products and Manufacturing: Manufacturing, marketing, and distribution of premium pet food, animal health products, and veterinary supplies, utilizing dedicated manufacturing facilities in Australia to supply retail stockists, pet stores, and veterinary clinics.
equipe executiva do EBOS Group
- Adam Luke HallChief Executive Officer
- Alistair GrayChief Financial Officer
- Leonard HansenChief Accountant & Chief Risk Officer
- Mithran NaikerChief Information Officer
- Cameron SinclairHead of Investor Relations
- Janelle CainGeneral Counsel
- Jacinta McCarthyExecutive General Manager of Human Resources
- Simon BundeExecutive General Manager of Strategic Operations, ESG & Innovation
- Grant VineyChief Executive Officer of EBOS Animal Care
- Kristine JamesCEO of Medical Technology
Comunicados recentes
O que a EBOS Group (EBO) comunicou ao mercado, do mais recente para o mais antigo.
- NZX Capital Change Notice - Options
- NZX Capital Change Notice - Performance Rights
- Notification regarding unquoted securities - EBO
- Notification regarding unquoted securities - EBO
- NZX Performance Rights Update
- Notification of cessation of securities - EBO
- NZX Capital Change Notice
- Application for quotation of securities - EBO
Histórico de dividendos
Dividendos por ação pagos pela EBOS Group, por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2027(até o momento) | A$0.4481 | — | — | A$0.4481 |
| FY2026 | A$0.4919 | — | — | A$0.9120 |
| FY2025 | A$0.5043 | A$0.4589 | — | A$0.9632 |
| FY2024 | A$0.4705 | A$0.4683 | — | A$0.9388 |
| FY2023 | A$0.3800 | A$0.4259 | A$0.0187 | A$0.8246 |
Principais indicadores financeiros
Resultados divulgados pela EBOS Group, em NZD.
- Cap. de mercado
- 3,4 bi
- Receita (TTM)
- 13,5 bi
- P/L
- 14.1
- LPA (diluído, TTM)
- 1.1
- Dividend yield
- 6.1%
- Margem de lucro
- 1.7%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 12,8 bi | 359,3 mi | 214 mi | |
| 12,2 bi | 420,7 mi | 213,9 mi | |
| 13,1 bi | 481 mi | 270,7 mi | |
| 12,2 bi | 447,8 mi | 253,6 mi |